Generic Bactrim is usually listed in the United States under its two active ingredient names, sulfamethoxazole and trimethoprim, or the abbreviation TMP-SMX. FDA-approved generics must meet applicable requirements for the corresponding reference medicine, but a search result displaying “sulfamethoxazole” alone is not the same product. Both ingredients and their amounts must appear in the product identification.
The usual oral tablet families contain sulfamethoxazole 400 mg with trimethoprim 80 mg or sulfamethoxazole 800 mg with trimethoprim 160 mg. Generic oral suspension is a different dosage form, commonly labeled 200 mg/40 mg per 5 mL. These descriptions identify products, not dosing instructions or permission to convert between forms. The dispensing pharmacist must match an authorized prescription.
This page explains how to recognize approved generics and ask about substitution. For a focused brand comparison, use the Bactrim-versus-generic analysis; for product-specific packaging, see the tablet-family overview.
A label may say “sulfamethoxazole and trimethoprim,” “SMX-TMP,” “TMP-SMX,” or a recognizable brand. Check that both components appear together, not just one. This is particularly important when a pharmacy search groups items by partial names or the order of ingredients on an electronic record.
The FDA evaluates generic applications against relevant criteria, including active ingredients, strength, dosage form and bioequivalence where required. The Orange Book records therapeutic-equivalence evaluations for listed products. This is stronger evidence than a seller’s unsupported statement that any two medicines are “the same.”
The fixed combination appears in single-strength and double-strength oral tablets, plus liquid presentations. The amount of each ingredient—not a marketing phrase such as “stronger”—identifies the product. The 800/160 mg generic-tablet page and the oral liquid guide cover different item-level checks.
For a liquid prescription, verify the concentration is expressed per 5 mL and that the pharmacist supplies an appropriate measuring device. For a tablet prescription, match either the 400/80 mg or 800/160 mg pair before comparing manufacturers. Equal-looking bottles or similar pill counts do not resolve a two-ingredient strength mismatch.
The table distinguishes the two individual tablet strengths from the liquid formulation. A brand request is a separate dispensing question, not a fourth generic dosage form. Read the sulfamethoxazole and trimethoprim amounts together, then confirm route, prescribed quantity, directions and any substitution restrictions.
| Product on prescription | Typical component label | Must verify |
|---|---|---|
| Standard-strength tablet | SMX 400 mg / TMP 80 mg | Single-strength instruction and tablet count |
| Double-strength tablet | SMX 800 mg / TMP 160 mg | DS instruction and tablet count |
| Oral suspension | SMX 200 mg / TMP 40 mg per 5 mL | Prescribed liquid, concentration and device |
| Brand request | Bactrim or Bactrim DS name | Whether substitution is allowed and approved |
The name on the carton may be a labeler, repackager or distributor rather than the physical plant that made the drug. An NDC can help identify the listed product but does not prove that it is FDA-approved or currently available. The manufacturer and labeler guide explains how to verify this distinction.
Pharmacies sometimes obtain an equivalent approved product from a different supplier. Confirm the combination, strength, oral form and prescribed instructions; ask the pharmacist about the appropriate therapeutic-equivalence basis. The fact that tablet appearance differs does not by itself establish a quality difference, and the patient should not infer equivalence from appearance alone.
Generics may be less expensive than a branded reference product, but the patient’s price also depends on pharmacy contracts, quantity, payment method and insurance. Ask for the total price on the exact authorized fill, not the lowest generic price shown in a search snippet.
Generic TMP-SMX carries the relevant ingredient-related warnings, including sulfonamide hypersensitivity, serious skin reactions, renal and potassium considerations and interacting medicines. A generic substitution changes the manufacturer or product label, not the need to assess these risks before dispensing.
Sulfamethoxazole and trimethoprim, commonly abbreviated TMP-SMX or SMX-TMP.
No. It is a fixed combination of two active ingredients.
The tablet contains 800 mg sulfamethoxazole and 160 mg trimethoprim.
No. Oral dosage form and concentration require an appropriate prescription and pharmacist verification.
Yes. Approved generics must meet FDA requirements for quality and demonstrated equivalence to applicable reference products.
Appearance can differ across suppliers. Verify the imprint, ingredients, strength and pharmacy label.
No. It remains a prescription antibiotic in the United States.